Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome
Status:
COMPLETED
Trial end date:
2025-01-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with interstitial cystitis/bladder pain syndrome, compared to placebo.